Frontiers in Cell and Developmental Biology (Jun 2024)
Corrigendum: ACE2 knockout hinders SARS-CoV-2 propagation in iPS cell-derived airway and alveolar epithelial cells
- Ryo Niwa,
- Ryo Niwa,
- Kouji Sakai,
- Kouji Sakai,
- Mandy Siu Yu Lung,
- Tomoko Matsumoto,
- Ryuta Mikawa,
- Ryuta Mikawa,
- Shotaro Maehana,
- Shotaro Maehana,
- Masato Suzuki,
- Yuki Yamamoto,
- Thomas L. Maurissen,
- Ai Hirabayashi,
- Takeshi Noda,
- Takeshi Noda,
- Makoto Kubo,
- Makoto Kubo,
- Shimpei Gotoh,
- Shimpei Gotoh,
- Knut Woltjen
Affiliations
- Ryo Niwa
- Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan
- Ryo Niwa
- Graduate School of Medicine, Kyoto University, Kyoto, Japan
- Kouji Sakai
- Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan
- Kouji Sakai
- Management Department of Biosafety, Laboratory Animal and Pathogen Bank, National Institute of Infectious Diseases, Tokyo, Japan
- Mandy Siu Yu Lung
- Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan
- Tomoko Matsumoto
- Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan
- Ryuta Mikawa
- Graduate School of Medicine, Kyoto University, Kyoto, Japan
- Ryuta Mikawa
- Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan
- Shotaro Maehana
- Department of Microbiology, Kitasato University School of Allied Health Sciences, Kanagawa, Japan
- Shotaro Maehana
- Regenerative Medicine and Cell Design Research Facility, Kitasato University School of Allied Health Sciences, Kanagawa, Japan
- Masato Suzuki
- Antimicrobial Resistance Research Center, National Institute of Infectious Diseases (NIID), Tokyo, Japan
- Yuki Yamamoto
- Graduate School of Medicine, Kyoto University, Kyoto, Japan
- Thomas L. Maurissen
- Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan
- Ai Hirabayashi
- Laboratory of Ultrastructural Virology, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan
- Takeshi Noda
- Laboratory of Ultrastructural Virology, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan
- Takeshi Noda
- 0Laboratory of Ultrastructural Virology, Graduate School of Biostudies, Kyoto University, Kyoto, Japan
- Makoto Kubo
- Department of Microbiology, Kitasato University School of Allied Health Sciences, Kanagawa, Japan
- Makoto Kubo
- Regenerative Medicine and Cell Design Research Facility, Kitasato University School of Allied Health Sciences, Kanagawa, Japan
- Shimpei Gotoh
- Graduate School of Medicine, Kyoto University, Kyoto, Japan
- Shimpei Gotoh
- Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan
- Knut Woltjen
- Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan
- DOI
- https://doi.org/10.3389/fcell.2024.1407164
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords